Literature DB >> 29651914

Inflammatory pathways are central to posterior cerebrovascular artery remodelling prior to the onset of congenital hypertension.

Dawid Walas1, Karol Nowicki-Osuch2, Dominic Alibhai3, Eva von Linstow Roloff1, Jane Coghill4, Christy Waterfall4, Julian Fr Paton1,5.   

Abstract

Cerebral artery hypoperfusion may provide the basis for linking ischemic stroke with hypertension. Brain hypoperfusion may induce hypertension that may serve as an auto-protective mechanism to prevent ischemic stroke. We hypothesised that hypertension is caused by remodelling of the cerebral arteries, which is triggered by inflammation. We used a congenital rat model of hypertension and examined age-related changes in gene expression of the cerebral arteries using RNA sequencing. Prior to hypertension, we found changes in signalling pathways associated with the immune system and fibrosis. Validation studies using second harmonics generation microscopy revealed upregulation of collagen type I and IV in both tunica externa and media. These changes in the extracellular matrix of cerebral arteries pre-empted hypertension accounting for their increased stiffness and resistance, both potentially conducive to stroke. These data indicate that inflammatory driven cerebral artery remodelling occurs prior to the onset of hypertension and may be a trigger elevating systemic blood pressure in genetically programmed hypertension.

Entities:  

Keywords:  Cerebrovascular remodelling; fluorescent microscopy; genetic hypertension; inflammatory pathways; transcriptomic plasticity

Mesh:

Year:  2018        PMID: 29651914      PMCID: PMC6724458          DOI: 10.1177/0271678X18769180

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  61 in total

1.  PANTHER: a library of protein families and subfamilies indexed by function.

Authors:  Paul D Thomas; Michael J Campbell; Anish Kejariwal; Huaiyu Mi; Brian Karlak; Robin Daverman; Karen Diemer; Anushya Muruganujan; Apurva Narechania
Journal:  Genome Res       Date:  2003-09       Impact factor: 9.043

2.  Vertebral and internal carotid arteries in relation to hypertension and cerebrovascular disease.

Authors:  C J DICKINSON; A D THOMASON
Journal:  Lancet       Date:  1959-07-18       Impact factor: 79.321

Review 3.  Pulse pressure, endothelium function, and arterial stiffness in spontaneously hypertensive rats.

Authors:  M Safar; P Chamiot-Clerc; G Dagher; J F Renaud
Journal:  Hypertension       Date:  2001-12-01       Impact factor: 10.190

4.  Collagen I and III and mechanical properties of conduit arteries in rats with genetic hypertension.

Authors:  P Chamiot Clerc; J F Renaud; J Blacher; M Legrand; J L Samuel; B I Levy; J Sassard; M E Safar
Journal:  J Vasc Res       Date:  1999 Mar-Apr       Impact factor: 1.934

Review 5.  Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors.

Authors:  M E Safar
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-03       Impact factor: 2.894

6.  Left and right ventricular collagen type I/III ratios and remodeling post-myocardial infarction.

Authors:  S Wei; L T Chow; I O Shum; L Qin; J E Sanderson
Journal:  J Card Fail       Date:  1999-06       Impact factor: 5.712

Review 7.  Collagens and atherosclerosis.

Authors:  M J Barnes; R W Farndale
Journal:  Exp Gerontol       Date:  1999-07       Impact factor: 4.032

Review 8.  Role of Gadd45 in apoptosis.

Authors:  M S Sheikh; M C Hollander; A J Fornance
Journal:  Biochem Pharmacol       Date:  2000-01-01       Impact factor: 5.858

9.  Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease.

Authors:  Kwang Hoon Lee; Hae-Shin Chung; Hyoung Sup Kim; Sang-Ho Oh; Moon-Kyung Ha; Ja-Hyun Baik; Sungnack Lee; Dongsik Bang
Journal:  Arthritis Rheum       Date:  2003-07

Review 10.  Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis.

Authors:  Bice Fubini; Andrea Hubbard
Journal:  Free Radic Biol Med       Date:  2003-06-15       Impact factor: 7.376

View more
  6 in total

1.  Neuronal Networks in Hypertension: Recent Advances.

Authors:  Patrice G Guyenet; Ruth L Stornetta; George M P R Souza; Stephen B G Abbott; Virginia L Brooks
Journal:  Hypertension       Date:  2020-06-29       Impact factor: 10.190

Review 2.  Rostral Ventrolateral Medulla and Hypertension.

Authors:  Patrice G Guyenet; Ruth L Stornetta; Benjamin B Holloway; George M P R Souza; Stephen B G Abbott
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

3.  Multiple-Tissue and Multilevel Analysis on Differentially Expressed Genes and Differentially Correlated Gene Pairs for HFpEF.

Authors:  Guofeng Zhou; Shaoyan Sun; Qiuyue Yuan; Run Zhang; Ping Jiang; Guangyu Li; Yong Wang; Xiao Li
Journal:  Front Genet       Date:  2021-07-08       Impact factor: 4.599

4.  Global proteomic analysis of extracellular matrix in mouse and human brain highlights relevance to cerebrovascular disease.

Authors:  Alexandra Pokhilko; Gaia Brezzo; Lahiru Handunnetthi; Raphael Heilig; Rachel Lennon; Colin Smith; Stuart M Allan; Alessandra Granata; Sanjay Sinha; Tao Wang; Hugh S Markus; Alexandra Naba; Roman Fischer; Tom Van Agtmael; Karen Horsburgh; M Zameel Cader
Journal:  J Cereb Blood Flow Metab       Date:  2021-03-17       Impact factor: 6.960

5.  Combination of Systems Pharmacology and Experimental Evaluation to Explore the Mechanism of Synergistic Action of Frankincense-Myrrh in the Treatment of Cerebrovascular Diseases.

Authors:  Yucheng Liao; Jingwen Wang; Chao Guo; Min Bai; Bowei Ju; Zheng Ran; Junping Hu; Jianhua Yang; Aidong Wen; Yi Ding
Journal:  Front Pharmacol       Date:  2022-01-10       Impact factor: 5.810

Review 6.  Vasculo-Neuronal Coupling and Neurovascular Coupling at the Neurovascular Unit: Impact of Hypertension.

Authors:  Jessica L Presa; Flavia Saravia; Zsolt Bagi; Jessica A Filosa
Journal:  Front Physiol       Date:  2020-09-25       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.